Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Windlas Biotech Limited Call Transcript 2026

Jan 29, 2026

59578_rns_2026-01-29_515875a9-04c5-4695-a308-ec3d3c109eb1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Windlas Biotech Limited

==> picture [164 x 33] intentionally omitted <==

Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199

Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030

CIN-L74899UR2001PLC033407

January 29, 2026

To Listing / Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

To

Listing / Compliance Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051

BSE CODE: 543329

NSE SYMBOL: WINDLAS

Dear Sir/ Madam,

Sub.: Schedule of Conference Call to discuss financial performance for the quarter and nine months ended December 31, 2025

With reference to the captioned subject and pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the conference call to discuss financial performance of the Company for the quarter and nine months ended December 31, 2025 is scheduled to be held as per the details given below:

Day Friday
Date February 6, 2026
Time 12:00 P.M., IST
Invite Refer Invite appended below

We enclose herewith details of the conference call issued by the Company which is self-explanatory and Conference Call invite is being uploaded on the website of the Company i.e. www.windlas.com.

You are requested to take the same on record.

Thanking you.

Yours faithfully,

For Windlas Biotech Limited

ANANTA NARAYAN PANDA 2026.01.29 13:46:44 +05'30' 11.0.10

Ananta Narayan Panda Company Secretary & Compliance Officer

Encl: as above

www.windlas.com

==> picture [154 x 32] intentionally omitted <==

==> picture [134 x 89] intentionally omitted <==

We cordially invite you to the Q3 & 9MFY26 Earnings Call of Windlas Biotech Limited

Friday, 6th February 2026 | 12:00 PM IST

Management Representative:

Mr. Hitesh Windlass (Managing Director)

Ms. Komal Gupta (CEO and CFO)

Dial in details:

Primary Numbers: +91 22 6280 1256 +91 22 7115 8157

International Toll Free:

  • Hong Kong: 800 964 448

  • Singapore: 800 101 2045

  • UK: 0 808 101 1573

  • USA: 1 866 746 2133

Diamond Pass Link

==> picture [20 x 24] intentionally omitted <==

For Further Information Contact:

Ankit Jain: [email protected] Omkar Sawant: [email protected] Contact No : +91 22 6239 8024

==> picture [150 x 35] intentionally omitted <==